Top Markets
#1 Nesa Nesa +779.11%
#2 Cortex Cortex +68.69%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.71%
#4 QuantixAI QuantixAI +32.43%
#5 EXOD EXOD +22.78%
#6 Pons Pons +16.57%
#7 Venom Venom +11.50%
#8 Movement Movement +10.89%
#9 Fartcoin Fartcoin +9.91%
#10 PondCoin PondCoin +8.96%
Coin of the day
Nesa Nesa
設定
言語
日本
通貨
USD
テーマ
Gan & Lee Pharmaceuticals. Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals.

603087
株式のランク #3118
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
株価
$10.27
時価総額
$6.14B
変化（1日）
3.08%
変化（1年）
3.63%
国
CN
取引 Gan & Lee Pharmaceuticals. (603087)

カテゴリー

Healthcare
Gan & Lee Pharmaceuticals.（603087）の利益
2026 時点の利益 TTM: 0
Gan & Lee Pharmaceuticals. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Gan & Lee Pharmaceuticals. の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
$3.81B -
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
$4.11B -
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
- -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
$1.59B -
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
- -
CH